SCHEMBL7284916

SCHEMBL7284916

CN(C)c1cc(C=O)cc(N(C)C)c1

nearest known ligand 0.58

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 2/20 0.58
CYP2A13 Q16696 1/20 0.58
ALDH1A1 P00352 4/20 0.38
ALDH3A1 P30838 1/20 0.38
ALDH1A3 P47895 1/20 0.38
TSHR P16473 3/20 0.37
ALOX15 P16050 1/20 0.36
HSD17B10 Q99714 1/20 0.36
APP P05067 2/20 0.34
HSD17B3 P37058 1/20 0.34
RELA Q04206 1/20 0.33
PTGS1 P23219 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
LMNA P02545 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
SRC P12931 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1662928 0.95 CYP2A6 (0.58) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL29954356 0.84 PTGS1 (0.48) CYP2A6CYP2A13ALDH1A1TSHRAPP
SCHEMBL5202353 0.84 CYP2A6 (0.48) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL1764812 0.80 CYP2A6 (0.44) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL6815808 0.80 CYP2A6 (0.44) CYP2A6CYP2A13ALDH1A1LMNA
SCHEMBL12555616 0.80 CYP2A6 (0.44) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL14291516 0.80 CYP2A6 (0.44) CYP2A6CYP2A13TSHR
SCHEMBL10364555 0.78 CYP2A6 (0.47) CYP2A6CYP2A13ALDH1A1RELAMAPK1
SCHEMBL28801518 0.77 CYP2A6 (0.41) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3
SCHEMBL29740784 0.77 CYP2A6 (0.56) CYP2A6CYP2A13ALDH1A1ALDH3A1ALDH1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023010191-A1 N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV1.7 AND/OR NAV1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME, AND KITS EUROFARMA LABORATÓRIOS S.A. (BR) 2023-02-09 WO disclosed
US-5691341-A ANTILEUKEMIA AGENT OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-11-25 US disclosed
US-5464833-A Anticarcinogenic agents, antiretrovirus agents or autoimmune diseases OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-11-07 US disclosed
EP-0623598-A1 APOPTOSIS REGULATOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-11-09 EP disclosed
US-4760064-A Cardiotonic agent OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1988-07-26 US disclosed
US-4616069-A REACTING THE ALKALI METAL OR ALKALINE EARTH METAL TERMINATED POLYMER WITH TIN COMPOUND AND ORGANIC COMPOUND HAVING AMIDE OR THIOAMIDE LINKAGES NIPPON ZEON CO., LTD. (JP) 1986-10-07 US disclosed
EP-0187322-A1 Carbostyril compounds, compositions containing same and processes for preparing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-07-16 EP disclosed